Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Boehringer Ingelheim (Schweiz) GmbH

02 2Macleods Pharmaceuticals Limited

03 1Teva Pharma AG

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Ipratropii bromidum anhydricum; Salbutamolum

Brand Name : Dospir

Dosage Form : Inhal L?s

Dosage Strength :

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Levosalbutamol

Brand Name :

Dosage Form : INHALATION AEROSOL (HFA BASED)

Dosage Strength : 50MCG

Packaging : 250 MD

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : United Kingdom

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Levosalbutamol

Brand Name :

Dosage Form : DPI CAPSULES

Dosage Strength : 100MCG

Packaging : 30 Capsules

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : United Kingdom

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Ipratropii bromidum anhydricum; Salbutamolum

Brand Name : Ipramol Sterilize

Dosage Form : Inhaled

Dosage Strength :

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank